Showing 1 - 9 results of 9 for search 'Yongyi Zeng', query time: 0.02s
Refine Results
-
1
-
2
Utilization of artificial circular RNAs as miRNA sponges and anti-PD-1 scFv expression platforms to suppress hepatocellular carcinoma progression by Yongping Lai, Yongping Lai, Fei Wang, Fei Wang, Guang Cai, Guang Cai, Yingying Li, Yingying Li, Jiaxin Weng, Feifan Cai, Feifan Cai, Leijie Cai, Leijie Cai, Niangmei Cheng, Niangmei Cheng, Bixing Zhao, Bixing Zhao, Yongyi Zeng, Yongyi Zeng, Yongyi Zeng, Yongyi Zeng
Published 2025-06-01Get full text
Article -
3
-
4
-
5
Multifunctional Biomimetic Nanocarriers for Dual‐Targeted Immuno‐Gene Therapy Against Hepatocellular Carcinoma by Yupeng Sun, Yan Liu, Rui Li, Cuilin Zhang, Ming Wu, Xiaolong Zhang, Aixian Zheng, Naishun Liao, Youshi Zheng, Haipo Xu, Rui Zeng, Yongyi Zeng, Xiaolong Liu
Published 2024-09-01Get full text
Article -
6
Targeted inhibition of PDGFRA with avapritinib, markedly enhances lenvatinib efficacy in hepatocellular carcinoma in vitro and in vivo: clinical implications by Bixing Zhao, Yang Zhou, Niangmei Cheng, Xiaoyuan Zheng, Geng Chen, Xin Qi, Xiangzhi Zhang, Fei Wang, Qiuyu Zhuang, Yehuda G. Assaraf, Xiaolong Liu, Yingchao Wang, Yongyi Zeng
Published 2025-05-01Get full text
Article -
7
Correction: Targeted Inhibition of PDGFRA with avapritinib, markedly enhances lenvatinib efficacy in hepatocellular carcinoma in vitro and in vivo: clinical implications by Bixing Zhao, Yang Zhou, Niangmei Cheng, Xiaoyuan Zheng, Geng Chen, Xin Qi, Xiangzhi Zhang, Fei Wang, Qiuyu Zhuang, Yehuda G. Assaraf, Xiaolong Liu, Yingchao Wang, Yongyi Zeng
Published 2025-05-01Get full text
Article -
8
Postoperative adjuvant therapy following radical resection for intrahepatic cholangiocarcinoma: A multicenter retrospective study by Lei Wang, Manjun Deng, Qiao Ke, Jianying Lou, Shuguo Zheng, Xinyu Bi, Jianming Wang, Wei Guo, Fuyu Li, Jian Wang, Yamin Zheng, Jingdong Li, Shi Cheng, Weiping Zhou, Yongyi Zeng
Published 2020-04-01Get full text
Article -
9
Personalized neoantigen hydrogel vaccine combined with PD-1 and CTLA-4 double blockade elicits antitumor response in liver metastases by activating intratumoral CD8+CD69+ T cells by Huan Yang, Ming Wu, Yongyi Zeng, Geng Chen, Zhixiong Cai, Xiaolong Liu, Da Zhang, Xiuqing Dong, Shichuan Tang, Ruijing Tang, Kongying Lin, Jun Fu, Yutong Guo, Fangzhou Lin, Tingfeng Huang, Jie Kong, Xiaowei Yin, Aimin Ge, Qizhu Lin
Published 2024-12-01Get full text
Article